alles over ongeneeslijke ziektes

Menopause and hormones

[The effect of hormonal replacement therapy on symptoms of climacteric syndrome and selected metabolic parameters].

4 Large controlled trial

What this means for you: this demonstrably works.
Type of study
controlled trial
Studied in
people
Participants
112
Published
2001 in Ginekologia polska
Cited
0 times by other research
Who paid
Not declared. PubMed carries no conflict-of-interest statement for most articles; that is not the same as independent.
Source
PubMed 11398578
The plain-language write-up of this study is still being written. Below is the abstract exactly as the researchers published it.
Abstract by the researchers — original text

GOAL OF STUDY: The goal of this paper was estimation of influence of HRT (after 3 and 6 months of treatment of 112 women) the symptoms of climacteric syndrome and depression associated with the said syndrome based on the scales of Kupperman, Green, Hamilton and Beck as well as some selected parameters of metabolic state--concentration of foloculotropic hormonal profile FSH and 17 beta-estradiol E2, lipid profile (TC, HDL, LDL, TG-A) and glucose concentration. CONCLUSIONS: 1. The implementation of hormonal replacement therapy on 112 women made it possible to conclude that the treatment caused withdrawal of symptoms of climacteric syndrome and depression associated with the said syndrome. 2. Hormonal Replacement Therapy to a great extent had a beneficial influence on the lipid profile with 112 women after menopause especially as far as LDL is concerned. 3. HRT caused enormously significant increase in 17 beta-estradiol concentration and decrease of FSH concentration. 4. HRT statistically had no impact on glucose level with the study group of women.